icon
icon
icon
icon
$300 Off
$300 Off

News /

Articles /

Knowles 2025 Q1 Earnings Misses Targets as Net Income Drops 180%

Daily EarningsWednesday, Apr 30, 2025 6:32 am ET
27min read
KN Trend
Knowles Corporation reported its fiscal 2025 Q1 earnings, showing a revenue decrease of 0.8% and a net income drop of 180.0% compared to 2024 Q1. The results fell short of expectations as net income swung to a loss. Despite uncertainty due to tariffs, the company maintains confidence in year-over-year growth for 2025. Guidance for Q2 2025 projects sequential revenue growth of 6% and year-over-year growth of 4%, suggesting potential improvement in performance.

Revenue

In the first quarter of 2025, Knowles Corporation's revenue experienced a slight decline of 0.8% compared to the same period in 2024. The Precision Devices segment generated $72.50 million, reflecting strong order activity and backlog. Meanwhile, the MedTech & Specialty Audio segment contributed $59.70 million, performing as expected. Overall, Knowles achieved total revenues of $132.20 million for Q1 2025.

Earnings/Net Income

Knowles experienced a significant downturn in its earnings for Q1 2025, swinging to a loss of $0.02 per share from a profit of $0.03 per share in Q1 2024. This downturn resulted in a net loss of $2 million, marking a 180.0% decline from the previous year's net income of $2.50 million. The EPS figures indicate a challenging quarter for Knowles.

Post-Earnings Price Action Review

Following Knowles Corporation's Q1 2025 earnings release, the stock exhibited varied performance based on key metrics such as revenue, net income, and EPS. The 3-day win rate for revenue was 61.90%, suggesting short-term price increases post-earnings. However, longer-term trends were less consistent, with 10-day and 30-day win rates at 52.38% and 42.86%, respectively. Net income showed a similar pattern, with medium-term performance more promising than short-term. EPS also indicated medium-term strength but variability in short-term and longer-term outcomes. Overall, these metrics suggest that Knowles' stock tends to benefit in the short to medium term following earnings announcements, though longer-term performance remains uncertain.

CEO Commentary

“I am pleased we completed the first quarter of 2025 with revenues at the high end of our guided range, cash provided by operating activities above our guided range, and non-GAAP diluted EPS from continuing operations at the mid-point of our guided range,” commented Jeffrey Niew, President, and CEO of Knowles. The Precision Devices segment continues to experience increased order activity and backlog in most end markets while the MedTech and Specialty Audio business continues to perform at expectations. Despite macro level uncertainty due to tariffs, demand remains strong, leading to increasing confidence in year-over-year growth across our businesses for 2025.

Guidance

For Q2 2025, Knowles expects revenues from continuing operations to be between $135 million and $145 million, with diluted earnings per share projected at $0.21 to $0.25. Additionally, net cash provided by operating activities is anticipated to range from $10 million to $20 million. The company’s revenue outlook reflects a sequential growth of 6% and a year-over-year growth of 4%.

Additional News

Knowles Corporation has announced a strategic increase in its stock repurchase program, with its Board of Directors authorizing an additional $150 million. This move, designed to enhance shareholder value, adds to the existing program launched in February 2020. As of February 13, 2025, approximately $194 million is available for share repurchases. Additionally, Knowles received a multi-year, $75 million order for high-performance capacitors in the Energy market, boosting its confidence in organic growth moving forward. The company's upcoming Investor Day on May 13th will further outline strategic plans for growth and development.

Ask Aime: Knowles Q1 Earnings Struggles Amid Tariff Uncertainty

Comments

Add a public comment...
Post
User avatar and name identifying the post author
therealchengarang
04/30
$KAI stock repurchase program boost is a nice move. Could be a signal they're confident in their future growth trajectory.
0
Reply
User avatar and name identifying the post author
Dynasty__93
04/30
MedTech holding strong, Precision Devices killin' it!
0
Reply
User avatar and name identifying the post author
Booknerdworm
04/30
180% net income drop? Oof, that's a tough quarter. But they're optimistic about growth. Maybe a value play here?
0
Reply
User avatar and name identifying the post author
rotundchungus
04/30
@Booknerdworm What do you think about their growth outlook?
0
Reply
User avatar and name identifying the post author
sendtoptilmir
04/30
@Booknerdworm Agreed, tough quarter but potential upside.
0
Reply
User avatar and name identifying the post author
Intelligent-Snow-930
04/30
KNowles might bounce back, but Q1 was a dud.
0
Reply
User avatar and name identifying the post author
Floriaskan
04/30
@Intelligent-Snow-930 Agreed, Q1 wasn't great.
0
Reply
User avatar and name identifying the post author
911Sheesh
04/30
@Intelligent-Snow-930 Think KNowles can rally soon?
0
Reply
User avatar and name identifying the post author
pd14200
04/30
Precision Devices killing it with strong orders. MedTech holding steady. If they hit Q2 targets, KNowles might be worth another look.
0
Reply
User avatar and name identifying the post author
portrayaloflife
04/30
CEO's optimistic, but tariffs got them shook.
0
Reply
User avatar and name identifying the post author
featherbirdcalls
04/30
@portrayaloflife True, tariffs can hit hard.
0
Reply
User avatar and name identifying the post author
PancakeBreakfest
04/30
KNowles might bounce back, but those EPS swings are wild. Holding a small position, watching to see how Q2 shapes up.
0
Reply
User avatar and name identifying the post author
Touma_Kazusa
04/30
Adding $KNX to my watchlist, potential long-term play.
0
Reply
User avatar and name identifying the post author
Senyorty12
04/30
KNowles' Precision Devices flexing with strong order activity, but MedTech needs to step up. 🚀
0
Reply
User avatar and name identifying the post author
TheRealJakeMalloy
04/30
OMG!Those $BABA whale-sized options block were screaming danger! � Closed positions just in time profiting more than $111
0
Reply
User avatar and name identifying the post author
JobKnown5705
04/30
@TheRealJakeMalloy What was the duration of holding those BABA options? Curious how long you were in the trade.
0
Reply
Disclaimer: The news articles available on this platform are generated in whole or in part by artificial intelligence and may not have been reviewed or fact checked by human editors. While we make reasonable efforts to ensure the quality and accuracy of the content, we make no representations or warranties, express or implied, as to the truthfulness, reliability, completeness, or timeliness of any information provided. It is your sole responsibility to independently verify any facts, statements, or claims prior to acting upon them. Ainvest Fintech Inc expressly disclaims all liability for any loss, damage, or harm arising from the use of or reliance on AI-generated content, including but not limited to direct, indirect, incidental, or consequential damages.
You Can Understand News Better with AI.
Whats the News impact on stock market?
Its impact is
fork
logo
AInvest
Aime Coplilot
Invest Smarter With AI Power.
Open App